Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study.
about
Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysisFront-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.
P2860
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Three-week schedule of irinote ...... a multicentre phase II study.
@en
Three-week schedule of irinote ...... a multicentre phase II study.
@nl
type
label
Three-week schedule of irinote ...... a multicentre phase II study.
@en
Three-week schedule of irinote ...... a multicentre phase II study.
@nl
prefLabel
Three-week schedule of irinote ...... a multicentre phase II study.
@en
Three-week schedule of irinote ...... a multicentre phase II study.
@nl
P2093
P1433
P1476
Three-week schedule of irinote ...... a multicentre phase II study.
@en
P2093
F Cardenal
G López-Vivanco
M Balcells
P304
P356
10.1016/S0169-5002(02)00512-3
P577
2003-02-01T00:00:00Z